(CLB)

Role: Director
Signature: /s/ Mark D. Tattoli, Attorney-in-Fact
Stock symbol: CLB
Transactions as of: Jun 28, 2023
Transactions value $: $0
Form type: 3
Date filed: 7/7/2023, 12:51 PM
Previous filing: Apr 28, 2023
Next filing: Jul 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLB	Common Shares						0	Jun 28, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLB	Restricted Shares							Jun 28, 2023	Common Shares	6.42K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.

Content

The Restricted Shares were granted to Mr. Anastasio upon his election to the Board of Directors of Core Laboratories Inc., as part of the annual grant given to all non-executive directors on April 1, 2023, and will vest, without performance criteria, on April 1, 2024, at the end of a one-year vesting period from the date of the original non-executive directors' grant, subject to the terms of issuance.